Cargando…
The Short-Term Effects of Intravitreal Injection of Bevacizumab on the Plasma Levels of Vascular Endothelial Growth Factor, Insulin-Like Growth Factor-1, and Growth Parameters in Infants with Retinopathy of Prematurity
PURPOSE: To determine the changes in serum levels of free vascular endothelial growth factor (VEGF), insulin-like growth factor-1 (IGF-1), and growth parameters in infants with retinopathy of prematurity (ROP) who received intravitreal injection of the bevacizumab (IVB). METHODS: A prospective inter...
Autores principales: | Sedaghat, Ahad, Abdolalizadeh, Parya, Parvaresh, Mohammad Mehdi, Ghorbanizadeh, Sajad, Mohagheghi, Parisa, Aghdam, Kaveh Abri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337023/ https://www.ncbi.nlm.nih.gov/pubmed/32671299 http://dx.doi.org/10.4103/JOCO.JOCO_78_20 |
Ejemplares similares
-
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Abrishami, Majid, et al.
Publicado: (2021) -
Parenteral Fish-Oil Lipid Emulsions in Retinopathy of Prematurity: A Retrospective Comparative Study
por: Gharehbaghi, Golnaz, et al.
Publicado: (2020) -
Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022) -
Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011) -
Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)